Earnings Call · Q2 FY2022·2022-01-27

Q2 22EPS -3.29%·Rev n/aQ1 22EPS +11.85%·Rev n/aQ4 21EPS +4.65%·Rev n/aQ3 21EPS +2.36%·Rev n/a⚠ consensus missing

RESMED INC RMD

Amy Wakeham — Chief Communications & Investor Relations Officer

Mick Farrell — Chief Executive Officer

Brett Sandercock — Chief Financial Officer

−3.9%1d on move date−6.4% vs SPY3d+3.2%5d+5.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more RMD calls or request research access.

More RMD calls Browse calls Request research access